Primary adenocarcinoma of the rete testis with elevation of serum carcinoembryonic antigen: a case report

Takeda, Shumpei; Yamashita, Shinichi; Kawamorita, Naoki; Mitsuzuka, Koji; Fujishima, Fumiyoshi; Watanabe, Mika; Ito, Akihiro; Arai, Yoichi

doi:10.1007/s13691-017-0280-3

Cited by 8 publications

(11 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Indeed, some reports on AORT have revealed serum CEA as an alternative marker. 7 The tumor marker levels were not elevated in our patient. Thus, differentiating between AORT and germ cell tumors is difficult without performing a histopathologic evaluation.…”

Section: Discussionmentioning

confidence: 42%

A case of adenocarcinoma of the rete testis with durable response to cisplatin‐based chemotherapy

et al. 2021

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 42%

A case of adenocarcinoma of the rete testis with durable response to cisplatin‐based chemotherapy

et al. 2021

View full text Add to dashboard Cite

show abstract

“…1 Recently, Takeda et al evaluated the demographic and clinical data of 51 cases. 2 As described above, the prognosis of disseminated cases was poor, and 1-and 3-year survival rates were reported to be 34% and 14%, respectively. 1 The most common metastatic sites were the lung and lymph nodes followed by the skin, liver, and bone.…”

Section: Editorial Commentmentioning

confidence: 89%

“…Patients range in age from their 10s to their 90s, with a mean in the 50s and a peak incidence around the 70s'. 1,2 Most cases exhibit painless scrotal swelling as a clinical symptom, and half of patients have a history of hydrocele. 1 Diagnosis is commonly made by histopathological analysis after high orchiectomy.…”

Section: Editorial Commentmentioning

confidence: 99%

“…One third of patients had metastases at presentation and half developed metastases after radical orchiectomy. 1,2 In nonmetastatic cases, after orchiectomy, although adjuvant radiotherapy for the retroperitoneal lymph node (RPLN) area does not appear to help, RPLN dissection may be a useful therapeutic modality. 1 The value of adjuvant chemotherapy remains unknown.…”

Section: Editorial Commentmentioning

confidence: 99%

“…1 The value of adjuvant chemotherapy remains unknown. 1,2 The 3-year survival rate of organ-confined cases was nearly 90%, 1,2 and the prognosis of disseminated cases was reported to be poor. 1 In this issue of IJU Case Reports, Owa et al reported a case of adenocarcinoma of the rete testis in a 48-year-old man with Down syndrome.…”

Section: Editorial Commentmentioning

confidence: 99%

See 2 more Smart Citations

Editorial Comment to A case of adenocarcinoma of the rete testis with durable response to cisplatin‐based chemotherapy

Yuasa

2021

IJU Case Reports

View full text Add to dashboard Cite

show abstract

Primary adenocarcinoma of the rete testis with elevated serum CA19-9 antigen levels

et al. 2020

View full text Add to dashboard Cite

Primary adenocarcinoma of the rete testis is an extremely rare tumor with a poor prognosis. Herein, we report a case of primary adenocarcinoma of the rete testis accompanied by elevated serum carbohydrate antigen 19-9 (CA19-9) antigen levels in a 44-year-old man who presented with left scrotal swelling. Para-aortic lymph node swelling was observed on the computed tomography scan. Germ cell tumor markers were within the normal range, but serum CA19-9 antigen levels were high. Radical orchiectomy was performed, and histological examination revealed primary adenocarcinoma of the rete testis with no evidence of other primary carcinomas. The patient underwent three lines of chemotherapy, although no reports suggest the use of gemcitabine and oxaliplatin (GEMOX) in a patient with adenocarcinoma of the rete testis. Unfortunately, he developed metastasis at multiple sites and passed away due to adenocarcinoma 13 months after undergoing orchiectomy. Some reports suggest that CA19-9 antigen levels are elevated in patients with adenocarcinoma of the rete testis, although it has not been clarified whether elevated CA19-9 antigen levels reflect the progression of adenocarcinoma of the rete testis. In this case, as CA19-9 antigen levels increased with progression, CA19-9 might be a marker for primary adenocarcinoma of the rete testis. GEMOX chemotherapy as a line of treatment in primary adenocarcinoma of the rete testis has not been reported. Therefore, further studies must evaluate the efficacy of the aforementioned chemotherapy regimen.

show abstract

Primary adenocarcinoma of the rete testis with elevation of serum carcinoembryonic antigen: a case report

Cited by 8 publications

References 10 publications

A case of adenocarcinoma of the rete testis with durable response to cisplatin‐based chemotherapy

A case of adenocarcinoma of the rete testis with durable response to cisplatin‐based chemotherapy

Editorial Comment to A case of adenocarcinoma of the rete testis with durable response to cisplatin‐based chemotherapy

Primary adenocarcinoma of the rete testis with elevated serum CA19-9 antigen levels

Contact Info

Product

Resources

About